Novel Pharmaceuticals That Use Anti-HLA Antibodies
AssigneesChugai Seiyaku Kabushiki Kaisha, The University of Tokushima
InventorsToshio Matsumoto, Shuji Ozaki, Masahiro Abe
Life of this patent
Estimating the term…
Loading patent…
AssigneesChugai Seiyaku Kabushiki Kaisha, The University of Tokushima
InventorsToshio Matsumoto, Shuji Ozaki, Masahiro Abe
Estimating the term…
The present inventors tested the effects of interferons on the expression of HLA-A in cells and cell injury caused by anti-HLA class I antibodies, by using a 2D7-DB antibody as an anti-HLA class I antibody and the IM-9 cell line as the cells to be tested. As a result, the expression of HLA-A was demonstrated to be upregulated by IFNα or IFNγ, Furthermore, WST-8 assays were performed to examine the cell viability when an interferon and an anti-HLA class I antibody were used in combination. As a result, cell death activity was found to be increased by the combination of 2D7-DB and IFNα or IFNγ.
A pharmaceutical composition comprising an interferon and an anti-HLA class I antibody as active ingredients.
A pharmaceutical composition comprising an anti-HLA class I antibody as an active ingredient, wherein the composition is used in combination with an interferon.
A pharmaceutical composition comprising an anti-HLA class I antibody as an active ingredient, wherein the composition is administered simultaneously with an interferon.
A pharmaceutical composition comprising an anti-HLA class I antibody as an active ingredient, wherein the composition is administered after administration of an interferon.
5-13. (canceled)
A method of treating or preventing a tumor in a patient, the method comprising administering to the patient an anti-HLA class I antibody and an interferon.
A method of treating or preventing an autoimmune disease in a patient, the method comprising administering to the patient an anti-HLA class I antibody and an interferon.
A method of inducing death of a cell, the method comprising administering to the cell an anti-HLA class I antibody and an interferon.
A method of enhancing an action of an anti-HLA class I antibody, the method comprising administering the anti-HLA class I antibody and an interferon to a cell.
Dependencies are inferred from the claim text.